HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of accompanying dyspnoea with diagnosis and outcome of patients presenting with acute chest discomfort.

AbstractAIMS:
The presence of accompanying dyspnoea is routinely assessed and common in patients presenting with acute chest pain/discomfort to the emergency department (ED). We aimed to assess the association of accompanying dyspnoea with differential diagnoses, diagnostic work-up, and outcome.
METHODS AND RESULTS:
We enrolled patients presenting to the ED with chest pain/discomfort. Final diagnoses were adjudicated by independent cardiologists using all information including cardiac imaging. The primary diagnostic endpoint was the final diagnosis. The secondary diagnostic endpoint was the performance of high-sensitivity cardiac troponin (hs-cTn) and the European Society of Cardiology (ESC) 0/1h-algorithms for the diagnosis of myocardial infarction (MI). The prognostic endpoints were cardiovascular and all-cause mortality at two years. Among 6045 patients, 2892/6045 (48%) had accompanying dyspnoea. The prevalence of acute coronary syndrome (ACS) in patients with vs. without dyspnoea was comparable (MI 22.4% vs. 21.9%, P = 0.60, unstable angina 8.7% vs. 7.9%, P = 0.29). In contrast, patients with dyspnoea more often had cardiac, non-coronary disease (15.3% vs. 10.2%, P < 0.001). Diagnostic accuracy of hs-cTnT/I concentrations was not affected by the presence of dyspnoea (area under the curve 0.89-0.91 in both groups), and the safety of the ESC 0/1h-algorithms was maintained with negative predictive values >99.4%. Accompanying dyspnoea was an independent predictor for cardiovascular and all-cause death at two years [hazard ratio 1.813 (95% confidence intervals, 1.453-2.261, P < 0.01)].
CONCLUSION:
Accompanying dyspnoea was not associated with a higher prevalence of ACS but with cardiac, non-coronary disease. While the safety of the diagnostic work-up was not affected, accompanying dyspnoea was an independent predictor for cardiovascular and all-cause death.
CLINICAL TRIAL REGISTRATION:
https://clinicaltrials.gov/ct2/show/NCT00470587, number NCT00470587.
AuthorsJasper Boeddinghaus, Thomas Nestelberger, Luca Koechlin, Pedro Lopez-Ayala, Desiree Wussler, Maximilian Mais, Luca Zwimpfer, Tobias Zimmermann, Karin Wildi, Maria Rubini Giménez, Ivo Strebel, Òscar Miró, F Javier Martin-Sanchez, Jiri Parenica, Dagmar I Keller, Danielle M Gualandro, Christian H Nickel, Roland Bingisser, Michael Christ, Christian Mueller, APACE investigators
JournalEuropean heart journal. Acute cardiovascular care (Eur Heart J Acute Cardiovasc Care) Vol. 12 Issue 5 Pg. 283-295 (May 04 2023) ISSN: 2048-8734 [Electronic] England
PMID36917461 (Publication Type: Journal Article)
Copyright© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: [email protected].
Chemical References
  • Biomarkers
  • Troponin T
Topics
  • Humans
  • Myocardial Infarction (diagnosis)
  • Predictive Value of Tests
  • Acute Coronary Syndrome
  • Prognosis
  • Chest Pain (diagnosis, etiology)
  • Dyspnea (diagnosis, epidemiology, etiology)
  • Biomarkers
  • Troponin T

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: